Pulmocit (A): Negotiating Pharmaceutical Products with the Government
通常価格
¥1,078 JPY
通常価格
セール価格
¥1,078 JPY
単価
あたり
税込み。
受取状況を読み込めませんでした
This is a two-party negotiation between a pharmaceutical company and a government agency to decide if a new medication will be put on the reimbursement list. The pharmaceutical company has a valuable new product, the government has semi-monopolistic power over whether (or not) drugs are listed. The role-play allows participants to negotiate given the inherent value-creation limitations of the setting.
【書誌情報】
ページ数:5ページ
サイズ:A4
商品番号:HBSP-INS387
発行日:2014/1/27
登録日:2014/5/28
